{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:34Z","timestamp":1789560154156,"version":"build-2803163510"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>Buprenorphine extended-release (XR) is an extended-release monthly injection to treat opioid use disorder (OUD). This retrospective case series includes 15 postpartum patients who were treated with buprenorphine-XR at a single center and reports on their outcomes. The average total daily sublingual buprenorphine dose before initiation of buprenorphine-XR was 16.25 mg (SD\u00b17.76, range 2\u201332 mg). Overall, 137 total doses of buprenorphine-XR were administered between May 17, 2021, and April 11, 2023. Urine toxicology test results were negative for opioids other than buprenorphine in the majority (80.0%) of patients once appropriate maintenance doses were achieved. Euphoria and intoxication were not reported. A minority of patients (20.0%) discontinued buprenorphine-XR. Although more extensive research is needed before widespread use, buprenorphine-XR may be a favorable treatment for OUD in this high-risk population.<\/jats:p>","DOI":"10.1097\/aog.0000000000005319","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T17:03:58Z","timestamp":1697735038000},"page":"1148-1152","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Buprenorphine Extended-Release Treatment for Opioid Use Disorder in the Postpartum Period"],"prefix":"10.1097","volume":"142","author":[{"given":"Bridget M.","family":"Galati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wenzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia E.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie C.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"J Substance Abuse Treat"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.2022.17045","article-title":"US trends in drug overdose mortality among pregnant and postpartum persons, 2017-2020","volume":"328","author":"Bruzelius","year":"2022","journal-title":"JAMA"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/AOG.0000000000005115","article-title":"Postpartum opioid-related mortality in patients with public insurance","volume":"141","author":"Suarez","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(18)32259-1","article-title":"Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"393","author":"Haight","year":"2019","journal-title":"Lancet"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/09540261.2021.1898349","article-title":"Addiction treatment in the postpartum period: an opportunity for evidence-based personalized medicine","volume":"33","author":"Martin","year":"2021","journal-title":"Int Rev Psychiatry"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/AOG.0000000000004126","article-title":"Subcutaneous buprenorphine extended-release use among pregnant and postpartum women","volume":"136","author":"Cleary","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/AOG.0000000000004270","article-title":"Subcutaneous buprenorphine extended-release use among pregnant and postpartum women","volume":"137","author":"Bernstein","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/ADM.0000000000000835","article-title":"The use of once-monthly injectable buprenorphine for the treatment of opioid use disorder in postpartum women: a case series","volume":"15","author":"Shadowen","year":"2021","journal-title":"J Addict Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:05:55Z","timestamp":1789556755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005319","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"2023-05-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}